Blog Profile / PharmaGossip

Filed Under:Medical / Pharmaceutical
Posts on Regator:10061
Posts / Week:27.3
Archived Since:March 4, 2008

Blog Post Archive

Tales from the PMCPA contd. - The case of the beer drinking, lederhosen wearing, presenter

?A pulmonologist working in Germany, complained about a scientific symposium organised by Boehringer Ingelheim at the European Respiratory Society (ERS) Congress held in Munich.The symposium was part of the industry sponsored sessions. Show More Summary

Mother brought to tears hearing Johnson & Johnson's Risperdal tactics

David Sell Posted: Friday, January 30, 2015, 8:05 AM Benita Pledger dabbed at her tears as she sat in a wooden chair outside a court room in Philadelphia's City Hall early Thursday evening. "I'm just having a hard time right now," she...Show More Summary

Maurice Saatchi's Medical Innovation Bill is more likely to make its proposer money than it is to help anyone who's sick.

Maurice Saatchi, his Medical Innovation Bill, and the booming ‘orphan drugs’ market Wikimedia Maurice Saatchi has had a great deal of media attention lately. This has focused for the most part on his Medical Innovation Bill (also known...Show More Summary

NICE - what's hot in 2015

The Medicines and Prescribing Centre at NICE has published the 2015 update to Key therapeutic topics - Medicines management options for local implementation (PDF).This publication summarises key therapeutic areas where there are potential...Show More Summary

Daiichi Sankyo Inc. Agrees to Pay $39 Million to Settle Kickback Allegations Under the False Claims Act

Department of JusticeOffice of Public AffairsFOR IMMEDIATE RELEASEFriday, January 9, 2015Daiichi Sankyo Inc., a global pharmaceutical company with its U.S. headquarters in New Jersey, has agreed to pay the United States and state Medicaid...Show More Summary

A letter from PharmedOut

Dear Friends of PharmedOut, Happy Holidays! We hope you saw Pharmed Out quoted in the New York Times last week. We are excited to tell you about our newest vision for PharmedOut in 2015 and beyond, and how you can help. As many of you have noted, silently or vocally, our website and social media presence need an update. Show More Summary

Ben Goldacre writes

Dear Friends Please help us make a real and lasting change. Two years ago I started discussing the problem of withheld trial data with Sense About Science. Back then, the situation seemed hopeless, and I was angry: many institutions were in denial, and many past efforts to fix the problem had ground to a halt. Show More Summary

Write a message to the NIH

Dear Friends Last month, many of you supported the WHO’s plan to call for the results of all clinical trials to be reported. Now we all need to support proposals from the US Government to improve clinical trial transparency there. The...Show More Summary

Ben Goldacre: Pharma industry has destroyed its own reputation

Ben Goldacre [Scott Hurst/Flickr] EXCLUSIVE: The great tragedy for the pharmaceutical industry is that it keeps denying that it lobbies against transparency in clinical trials, says Ben Goldacre. Ben Goldacre is a British physician, academic and author of the best-selling books Bad Science and Bad Pharma. Show More Summary

Copyright © 2015 Regator, LLC